In theory, the possibility of adverse events should be reduced when the virus is negative in patients with hepatitis B. Many researchers have also used HBV DNA, ALT, and AST as prognostic markers in patients with chronic HBV infection (22, 23). The gene discussed is GPT; the disease is hepatitis B virus infection.